Home

Embargo Session Minimum drägerwerk investor relations Effizienz Übermäßig Überschallgeschwindigkeit

Investment in Dräger | Dräger
Investment in Dräger | Dräger

Investment in Dräger | Dräger
Investment in Dräger | Dräger

DRÄGERWERK - Gelingt der Turnaround bereits 2023? | stock3
DRÄGERWERK - Gelingt der Turnaround bereits 2023? | stock3

Investment in Dräger | Dräger
Investment in Dräger | Dräger

First half of 2014:
First half of 2014:

Fiscal year 2017:
Fiscal year 2017:

Dräger countering negative earnings trend by launching turnaround program
Dräger countering negative earnings trend by launching turnaround program

Dräger starts tender offer for the participation certificates
Dräger starts tender offer for the participation certificates

First quarter of 2018:
First quarter of 2018:

Investment in Dräger | Dräger
Investment in Dräger | Dräger

Investment in Dräger | Dräger
Investment in Dräger | Dräger

Fiscal year 2018:
Fiscal year 2018:

A lightweight design that's tough enough for any incident
A lightweight design that's tough enough for any incident

Dräger publishes its sustainability report 2022
Dräger publishes its sustainability report 2022

First half of 2019: Dräger records solid net sales growth
First half of 2019: Dräger records solid net sales growth

Dräger acquires majority share of Swiss medical technology start-up ›STIMIT‹
Dräger acquires majority share of Swiss medical technology start-up ›STIMIT‹

Thomas Fischler - Head of Treasury & Investor Relations - Drägerwerk AG &  Co. KGaA | XING
Thomas Fischler - Head of Treasury & Investor Relations - Drägerwerk AG & Co. KGaA | XING